Hospital Based Continuous Patient Monitoring System
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-18
SponsorUniversity of Alabama at Birmingham
About this trial
In Ghana, and many other low and middle income countries in Africa, manual vital signs monitoring is the prevalent mode of vital signs monitoring because continuous bedside monitors are non-functional. This lack of continuous vital signs monitoring may result in missed opportunities to catch physiologic deterioration.
The investigators propose to develop a dashboard that is based on the Garmin Venu 3, a consumer wearable device that reliably measures heart rate, SPO2, and respiratory rate, as an alternative to bedside monitors in hospitals in Ghana.
Eligibility criteria
Qualifiers
Pediatric patients presenting with traumatic injury
Pediatric patients postoperative status after an appendectomy
Disqualifiers
Pediatric patients missing their upper limbs,
Pediatric patients who cannot wear a Fitbit on their wrist for known allergies to rubber or those with traumatic or medical conditions that prevent them from being able to comfortably wear a Fitbit on either hand
Trial design
Treatments tested in this trial
- Consumer Wearable Device Vital Sign Measurement
Treatment groups
250 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
Northwestern University
Collaborator
University of Chicago
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
University of Ghana
Collaborator
Loyola University
Collaborator
Fogarty International Center of the National Institute of Health
Collaborator
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov